On April 27th, Yangpu Medical (300030) (300030), an A-share listed company, released its annual performance report for 2023. Of which, the net loss is 6320.WorldcryptoheroesnftThe loss decreased by 68.13% compared with the same period last year.

According to the comprehensive operation and follow-up analysis of more than 1200 financial indicators of its financial data in the current period and the past five years, according to the financial diagnosis model of flush (300033), the overall financial situation of Yangpu Medical is lower than the industry average in the past five years. Specifically, the growth ability, asset quality is general, operating ability is good, cash flow is excellent.

The net loss was 63.2038 million yuan, which decreased by 68.13% compared with the same period last year.

In terms of revenue and profit, the company achieved total operating income of 645 million yuan during the reporting period, down 9.31% from the same period last year, with a net loss of 63.2038 million yuan, a loss of 68.13% over the same period last year, and basic earnings per share of-0.20 yuan.

In terms of assets, during the reporting period, the total assets at the end of the period were 1.426 billion yuan and the accounts receivable were 184 million yuan.WorldcryptoheroesnftIn terms of cash flow, the net cash flow generated by business activities was 79.9049 million yuan, and the cash received from the sale of goods and services was 771 million yuan.

There are two financial highlights.

According to the relevant financial information released by Yangpu Medical, there are two financial bright spots in the company, as follows:

Index types comment on cash flow free cash flow accounts for an average of 8.25% of income, and the company's cash flow is excellent. The average cash-to-cash ratio of the main business is 117.82%, and the company has a strong ability to realize its income.

The financial situation is poor, there are 7 financial risks

According to the relevant financial information released by Yangpu Medical, the company has seven financial risks, as follows:

The average rate of return on net assets is-4.32%, and the company's profitability is very weak. The average operating margin is-4.75%, and the company's ability to make money is very weak. The average year-on-year growth rate of performance deduction non-net profit is-532.52%, and the growth of the company is relatively low. The average growth rate of growth operating profit is-81.50% over the same period last year, and the company's growth ability is poor. The ratio of debt to interest payment is 28.31%, and there is a great pressure on debt repayment. The quick debt repayment ratio is 0.80, and the short-term solvency is very weak. The deduction of non-net profit in the growth period decreased by 130.24% compared with the same period last year, and the profit dropped greatly.

Overall, the overall financial situation of Yangpu Medical is lower than the industry average, with a current total score of 1.16, ranking low among 126 companies in the medical device industry. Specifically, the growth ability, asset quality is general, operating ability is good, cash flow is excellent.

The scores of the indicators are as follows:

Index type previous period score ranking evaluation growth ability 0.161.07100 general profitability 0.160.44116 lower solvency 0.400.36118 lower cash flow 3.594.4016 sufficient operating capacity 2.503.5338 good asset quality 1.081.16114 general total score lower than industry average

On the large model of financial diagnosis of flush

Flush (300033) Financial diagnosis model calculates the company's financial scores, highlights and risks based on the company's latest and previous financial data and industry conditions, reflecting the company's disclosed financial position, but not a forecast of the future financial position. The financial score range is 0-5. The higher the score, the better the financial situation and the greater the value of the medium-and long-term investment. In the financial highlights and risk reviews, the five-year average of the indicators related to the "average" keyword, and the latest reporting period data without the "average" keyword. All the above information is based on artificial intelligence algorithm, for reference only, does not represent flush financial point of view, investors operate accordingly, at their own risk.

Learn more about the company's stock diagnostic information >

(: congratulations